THE Therapeutic Goods
Administration has updated the list
of designated orphan drugs.
Isavuconazonium sulfate has
been added for the treatment of
invasive aspergillosis and invasive
mucormycosis while teduglutide
(Revestive) has been added for
treating Short Bowel Syndrome.The above article was sent to subscribers in Pharmacy Daily's issue from 12 Jan 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Jan 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.